ARCHIVES

Congressional Committee, SEC Probe ImClone’s Statements To Shareholders.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Retrovirus Vaccination Is Feasible, Workshop Participants Conclude

May 3, 1985

NCI To Recompete NSABP in 1995, Chabner tells Senate

May 20, 1994

In Brief: NCI To Push “Cancer Prevention Awareness” This Month; Three RFPs Delayed For Changes

February 17, 1984

DCT Board reluctantly Okays Resources Contracts Recompetition, $6 of $10 Million Competitively

April 1, 1977

IOM Committee Focuses on Studies Needed To Protect Patients On Omics-Based Trials

November 4, 2011

Kulig Will Oversee Outcomes Research at NCCN

September 30, 2011